We are an emerging leader with new solutions in the field of nuclear medicine technology

Explore Our Company

Products

Products

Our innovative products and technologies are designed to meet current and future demands for medical radioisotopes. They mark a new era for nuclear medicine technology.

Supply

Supply

Medical radioisotopes are critical to meet patient healthcare needs and advance clinical research. We’ve charted the course for producing a stable, reliable and domestically sourced isotope supply.

Commitment

Commitment

Our people drive our solutions. From providing domestic supply of isotopes for patients to national security and environmental sustainability, we are committed to advancing radioisotope technology to shape a better world.

About NorthStar

We are a nuclear medicine technology company committed to providing the United States with stable, domestic and environmentally friendly radioisotope supply solutions to meet the needs of patients and advance clinical research.  Our innovative technologies have the ability to fundamentally transform the ways that medical radioisotopes are produced and distributed around the world.

Learn More About NorthStar

Press Releases
May 4, 2021
NorthStar Medical Radioisotopes to Present at the Emerging Medtech Summit 2021

BELOIT, Wis., May 4, 2021 – NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and commercialization of radiopharmaceuticals used for therapeutic and medical imaging applications, today announced that Stephen Merrick, President and Chief Executive Officer of NorthStar Medical Radioisotopes, will present a corporate overview at the Emerging Medtech Summit 2021, on May 12, 2021 at 3:57 p.m.

Read More
Press Releases
April 13, 2021
NorthStar Medical Radioisotopes Provides Updates on Corporate Progress and Upcoming Milestones

− NorthStar has provided reliable molybdenum-99 (Mo-99)/technetium-99m (Tc-99m) supply for more than two years as the only U.S.

Read More
Press Releases
March 8, 2021
NorthStar Medical Radioisotopes and IBA Expand Collaboration to Enable Global Availability of Diagnostic Radioisotope Technetium-99m (Tc-99m)

− Technetium-99m is the daughter isotope of molybdenum-99 (Mo-99) – − Collaboration enables integrating technology expertise to provide Tc-99m Generation Systems (TCM Generation Systems) that utilize non-uranium based Mo-99 produced using electron beam accelerators − − Diagnostic imaging studies using Tc-99m inform healthcare decisions for approximately 30 million patients annually around the world – BELOIT, Wis.,

Read More

How Can We Help?

Questions about company, products, supply solutions, careers or anything else?

Contact Us Today